Aegon reports first half year 2025 results

Core Insights - Aegon reported strong commercial momentum in key markets during the first half of 2025, with notable increases in new life sales and net deposits across various regions [5][6][10] - The company is on track to meet its Operating Capital Generation (OCG) guidance for 2025, with a significant operating result increase compared to the previous year [6][10] - Aegon announced a review for relocating its legal domicile and head office to the United States, reflecting its strategic focus on the U.S. market [4][8][9] Financial Highlights - New life sales in the U.S. increased by 13% to USD 276 million [5] - The operating result for the first half of 2025 was EUR 845 million, up 19% year-on-year [6][10] - Net profit reached EUR 606 million, a significant recovery from a net loss of EUR 65 million in the first half of 2024 [10] Capital Highlights - Aegon reported EUR 576 million in Operating Capital Generation (OCG) for the first half of 2025, maintaining guidance of around EUR 1.2 billion for the year [6][10] - The company announced an interim dividend of EUR 0.19 per share, a 19% increase from the previous year [7][10] - Aegon is increasing its share buyback program to EUR 400 million, up from EUR 200 million [7][10] Strategic Developments - Aegon is reviewing the potential relocation of its head office to the U.S., where approximately 70% of its operations are concentrated [8][9] - The relocation aims to simplify the corporate structure by aligning legal domicile and regulatory frameworks with its primary market [9]